Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

CYLD Gene Analysis for Spiegler-Brooke Syndrome (NGS) in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين CYLD لمتلازمة شبيغلر-بروك (التسلسل الجيني من الجيل التالي) في الإمارات | 2800 درهم | إرشادات هيئة الصحة بدبي لعام 2026

99.9% Diagnostic Sensitivity through ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
🏥 Hospital-Grade Home Collection via ISO Certified Cold-Chain, 8 AM – 11 PM.
📞 Post-Test Clinical Guidance by DHA-Licensed Specialists.
💰 Direct Insurance Billing Verification via WhatsApp +971 54 548 8731.

معالجة مخبرية دقيقة بنسبة 99.9% مع خدمة جمع منزلي معتمدة بمعايير ISO واستشارة سريرية هاتفية بعد الفحص.

Clinical Overview

The CYLD gene analysis identifies germline mutations in the CYLD tumor suppressor gene, responsible for Spiegler-Brooke syndrome and increased risk of multiple benign skin adnexal tumors with possible malignant progression. This NGS-based test provides full coverage of coding exons and splice sites, delivering results in 3–4 weeks to support early surveillance and family screening. يحدد التحليل الطفرات الجينية الوراثية في جين CYLD المسؤول عن متلازمة شبيغلر-بروك وأورام الجلد الحميدة المتعددة.

Feature Our CYLD NGS Test Closest Alternative (Single Exon Screening)
Diagnostic Precision Full gene sequencing with >99% analytical sensitivity and Sanger confirmation Limited to preselected exons, risk of false-negative results
Methodology Next Generation Sequencing (Illumina® platform, validated bioinformatics) Conventional Sanger sequencing, often batched with longer delays
Turnaround Time 3–4 Weeks (comprehensive clinical report) 6–8 Weeks if full gene coverage is attempted

Physician’s Perspective and Safety Protocol

“As a clinician, I understand the anxiety surrounding hereditary cancer syndromes – a positive CYLD test guides tailored screening and can prevent late-stage complications. Any genetic result must be correlated with personal and family history.”

– Dr. PRABHAKAR REDDY, Oncologist (DHA License: 61713011)

⚠️ Medication Warning: Do not discontinue any prescribed medication without consulting your doctor. This test does not replace ongoing oncology follow-up.

🚨 Safety Parameters & Urgent Symptoms

  • Exclusion Criteria: Active febrile illness, recent blood transfusion (within 2 weeks), or chemotherapy that may affect DNA yield.
  • ER Red Flags (pre‑test): Rapidly growing or ulcerated skin lesions, new bleeding, or persistent pain. Seek immediate dermatologic evaluation before proceeding with genetic testing.
  • Patient Condition: Pregnant or breastfeeding patients can undergo testing; genetic counseling is mandatory for minors per UAE CDS Law 2026.

Patient FAQ & Clinical Guidance

1. What is the purpose of the CYLD Gene Spiegler-Brooke Syndrome NGS test?

This test identifies pathogenic variants in the CYLD gene to confirm a clinical diagnosis of Spiegler-Brooke syndrome, guiding cancer surveillance and familial risk assessment.

يكشف هذا الفحص عن الطفرات المسببة في جين CYLD لتأكيد تشخيص متلازمة شبيغلر-بروك وتوجيه المراقبة السرطانية وتقييم المخاطر العائلية. الاستشارة الوراثية قبل الفحص ضرورية لفهم النتائج المحتملة.

2. How is the sample collected and what is the turnaround time?

A simple blood draw, buccal swab, or dried blood spot on FTA card is collected by a certified phlebotomist at your home or clinic; results are delivered in 3 to 4 weeks.

يتم جمع العينة عبر سحب دم بسيط أو مسحة شدق أو بطاقة FTA بواسطة مسعف معتمد منزلياً، وتصدر النتائج خلال 3 إلى 4 أسابيع.

3. Are there any preparation requirements or need for genetic counseling?

Pre‑ genetic counseling is mandatory to review your personal and family history, discuss potential outcomes, and understand implications for relatives; no fasting is required.

الاستشارة الوراثية قبل الفحص إلزامية لمراجعة التاريخ العائلي ومناقشة النتائج المحتملة وتأثيرها على الأقارب، ولا يلزم الصيام قبل الفحص.

UAE Regulatory Compliance & Accreditation

Licensed Medical Laboratory Facility No.: 9834453. This service fully adheres to Federal Decree‑Law No. 41 of 2024 (Art. 87), UAE CDS Law 2026 (Minors Protection), and UAE Personal Data Protection Law (PDPL). All genetic data are stored securely under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) and processed within DHA-audited protocols.

Home collection available daily 8 AM – 11 PM. For insurance inquiries or to book, call/WhatsApp: +971 54 548 8731.

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians